These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3091779)

  • 21. Inhibition of mitomycin C's aerobic toxicity by the seleno-organic antioxidant PZ-51.
    Gustafson DL; Pritsos CA
    Cancer Chemother Pharmacol; 1991; 28(3):228-30. PubMed ID: 1906786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution and excretion of 7-N-(p-hydroxyphenyl)-mitomycin C in normal mice.
    Imai R; Morimoto M; Marumo H
    Gan; 1982 Aug; 73(4):675-80. PubMed ID: 6818093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carnitine or dimethyl sulfoxide, or both, for the treatment of anthracycline extravasation in rats.
    Uzunoglu S; Cosar R; Cicin I; Ibis K; Demiralay E; Benlier E; Erdogan B; Kandulu H; Ozen A; Altaner S
    J Plast Surg Hand Surg; 2013 Oct; 47(5):339-43. PubMed ID: 23710793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor activity and toxicity in animals of BMY-25282, a new mitomycin derivative.
    Bradner WT; Rose WC; Schurig JE; Florczyk AP; Huftalen JB; Catino JJ
    Cancer Res; 1985 Dec; 45(12 Pt 1):6475-81. PubMed ID: 3933826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disposition and pharmacokinetics of a polymeric prodrug of mitomycin C, mitomycin C-dextran conjugate, in the rat.
    Hashida M; Kato A; Takakura Y; Sezaki H
    Drug Metab Dispos; 1984; 12(4):492-9. PubMed ID: 6148218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DMSO protects against adriamycin-induced tissue necrosis.
    Lebredo L; Barrie R; Woltering EA
    J Surg Res; 1992 Jul; 53(1):62-5. PubMed ID: 1405593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic efficacy of a lipid-based prodrug of mitomycin C in pegylated liposomes: studies with human gastro-entero-pancreatic ectopic tumor models.
    Gabizon A; Amitay Y; Tzemach D; Gorin J; Shmeeda H; Zalipsky S
    J Control Release; 2012 Jun; 160(2):245-53. PubMed ID: 22134116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of anthracycline extravasation in mice with dexrazoxane with or without DMSO and hydrocortisone.
    Langer SW; Thougaard AV; Sehested M; Jensen PB
    Cancer Chemother Pharmacol; 2006 Jan; 57(1):125-8. PubMed ID: 16001176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Topical application of mitomycin C conjugated with dextran (MMC-D): a high molecular weight derivative of mitomycin C].
    Honda K; Satomura K; Hashida M; Sezaki H
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):530-5. PubMed ID: 2408576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective clinical study.
    Bertelli G; Gozza A; Forno GB; Vidili MG; Silvestro S; Venturini M; Del Mastro L; Garrone O; Rosso R; Dini D
    J Clin Oncol; 1995 Nov; 13(11):2851-5. PubMed ID: 7595748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of sodium thiosulfate as a local antidote to mechlorethamine skin toxicity in the mouse.
    Dorr RT; Soble M; Alberts DS
    Cancer Chemother Pharmacol; 1988; 22(4):299-302. PubMed ID: 3168143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced lymphatic delivery of mitomycin C conjugated with dextran.
    Takakura Y; Matsumoto S; Hashida M; Sezaki H
    Cancer Res; 1984 Jun; 44(6):2505-10. PubMed ID: 6202398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced anticancer efficacy by use of mitomycin C adsorbed on small activated carbon particles in mice.
    Hagiwara A; Takahashi T; Ueda T; Nakagawa Y
    Jpn J Cancer Res; 1987 Apr; 78(4):405-8. PubMed ID: 3108220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacologic Studies of a Prodrug of Mitomycin C in Pegylated Liposomes (Promitil(®)): High Stability in Plasma and Rapid Thiolytic Prodrug Activation in Tissues.
    Amitay Y; Shmeeda H; Patil Y; Gorin J; Tzemach D; Mak L; Ohana P; Gabizon A
    Pharm Res; 2016 Mar; 33(3):686-700. PubMed ID: 26572644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of antidotes for extravasation injury produced by 6-hydroxymethylacylfulvene (MGI 114), a novel cytotoxic antitumor agent, in an intradermal toxicity model in rats.
    Marshall RF; Arthaud LE; MacDonald JR
    Cancer Chemother Pharmacol; 2000; 45(5):397-401. PubMed ID: 10803923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced delivery of mitomycin C derivatives through hairless mouse and rat skins.
    Hashida M; Mukai E; Kimura T; Sezaki H
    J Pharm Pharmacol; 1985 Aug; 37(8):542-4. PubMed ID: 2864413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Induction of activated macrophages by intraperitoneal injection of mitomycin C in mice and rats].
    Ogura T
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):689-96. PubMed ID: 3083782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiosensitizing and cytotoxic properties of mitomycin C in a C3H mouse mammary carcinoma in vivo.
    Grau C; Overgaard J
    Int J Radiat Oncol Biol Phys; 1991 Feb; 20(2):265-9. PubMed ID: 1899413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Approaches to reducing toxicity of parenteral anticancer drug formulations using cyclodextrins.
    Bhardwaj R; Dorr RT; Blanchard J
    PDA J Pharm Sci Technol; 2000; 54(3):233-9. PubMed ID: 10927914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced toxicity and superior therapeutic activity of a mitomycin C lipid-based prodrug incorporated in pegylated liposomes.
    Gabizon AA; Tzemach D; Horowitz AT; Shmeeda H; Yeh J; Zalipsky S
    Clin Cancer Res; 2006 Mar; 12(6):1913-20. PubMed ID: 16551877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.